Sino Biopharmaceutical (00314.HK) spent approximately 253,100 Hong Kong dollars on June 26 to buy back 200,000 shares.

The Zhitong Finance and Economics APP reported that SPH Health (00314.HK) announced a repurchase of 200,000 shares for approximately HK$25.31 million on June 26, 2026.